$38.59
-0.05[-0.13%]
At close: Apr 19
$38.59
0[0.00%]
After Hours: 4:00PM EDT
Inari Medical
(NASDAQ:NARI)Latest News for Inari Medical Stock (NASDAQ:NARI)
Inari Medical Stock (NASDAQ: NARI)
Categories: All
Friday, April 12, 2024
Tuesday, March 26, 2024
Monday, March 25, 2024
- Inari Medical To Replace Callon Petroleum In S&P SmallCap 600, Effective Prior To The Opening Of Trading On Monday, April 1Benzinga Newsdesk - Mar 25, 2024, 5:21PM
- AppFolio To Replace Inari Medical In The S&P MidCap 400, Effective Prior To The Opening Of Trading On Monday, April 1Benzinga Newsdesk - Mar 25, 2024, 5:19PM
Friday, March 22, 2024
Tuesday, March 12, 2024
Wednesday, March 06, 2024
Thursday, February 29, 2024
- Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 29, 2024, 2:00PM
- Inari Medical shares are trading lower after the company reported mixed Q4 results and disclosed a DOJ investigation. Piper Sandler downgraded the stock to Neutral.Benzinga Newsdesk - Feb 29, 2024, 1:09PM
- Critical Insights From Inari Medical Analyst Ratings: What You Need To KnowBenzinga Insights - Feb 29, 2024, 11:01AM
- Needham Reiterates Buy on Inari Medical, Maintains $72 Price TargetBenzinga Newsdesk - Feb 29, 2024, 9:29AM
- Truist Securities Reiterates Hold on Inari Medical, Lowers Price Target to $61Benzinga Newsdesk - Feb 29, 2024, 9:16AM
- Canaccord Genuity Maintains Buy on Inari Medical, Lowers Price Target to $75Benzinga Newsdesk - Feb 29, 2024, 7:36AM
- Piper Sandler Downgrades Inari Medical to Neutral, Lowers Price Target to $55Benzinga Newsdesk - Feb 29, 2024, 6:51AM
- Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAvi Kapoor - Feb 29, 2024, 5:16AM
Wednesday, February 28, 2024
- Inari Medical Expects 2024 Revenue Of $580M-$595M (Est $588.336M); Still Expects To Reach Sustained Operating Profitability In H1 Of 2025Benzinga Newsdesk - Feb 28, 2024, 4:21PM
- Recap: Inari Medical Q4 EarningsBenzinga Insights - Feb 28, 2024, 4:10PM
- Inari Medical Q4 EPS $(0.08) Misses $0.01 Estimate, Sales $132.09M Beat $131.79M EstimateBenzinga Newsdesk - Feb 28, 2024, 4:06PM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, January 23, 2024
- Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: AnalystVandana Singh - Jan 23, 2024, 2:56PM
- Inari Medical Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)Benzinga Insights - Jan 23, 2024, 8:01AM
- Needham Initiates Coverage On Inari Medical with Buy Rating, Announces Price Target of $72Benzinga Newsdesk - Jan 23, 2024, 6:48AM
Tuesday, January 09, 2024
- Inari Medical shares are trading lower after the company reported preliminary Q4 and FY revenue guidance. Also, the company issued FY24 revenue guidance.Benzinga Newsdesk - Jan 9, 2024, 11:00AM
- Inari Medical Forecasts FY24 Revenue Of $580M-$595M, Up Approximately 17.5%-20.5% Y/Y Versus Consensus Of $583.65MBenzinga Newsdesk - Jan 9, 2024, 6:37AM
- Inari Medical Reports Preliminary Unaudited Revenue For Q4 Of 2023 Of At Least $132M, Up 22% Y/Y Versus Consensus Of $130.98M, With FY23 Preliminary Unaudited Revenue Of At Least $493.5M, Up 29% Y/Y Versus Consensus Of $492.61MBenzinga Newsdesk - Jan 9, 2024, 6:35AM
Friday, December 22, 2023
Monday, November 27, 2023
Thursday, November 09, 2023
Thursday, November 02, 2023
- Piper Sandler Maintains Overweight on Inari Medical, Lowers Price Target to $85Benzinga Newsdesk - Nov 2, 2023, 4:24PM
- Truist Securities Maintains Hold on Inari Medical, Raises Price Target to $65Benzinga Newsdesk - Nov 2, 2023, 3:55PM
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- Inari Medical shares are trading lower after the company reported Q3 results and announced it will acquire LimFlow for $250 million in cash.Benzinga Newsdesk - Nov 2, 2023, 12:23PM
Wednesday, November 01, 2023
- LimFlow Announces Agreement To Be Acquired by Inari Medical; LimFlow Will Receive $250M In Cash At Closing And Be Eligible To Receive Up To $165M In Additional Payments Based On Certain Commercial And Reimbursement Milestones Total Value Of $415MBenzinga Newsdesk - Nov 1, 2023, 5:08PM
- Inari Medical Q3 2023 Revenue $126.4M Beats $121.92M EstimateBenzinga Newsdesk - Nov 1, 2023, 4:21PM
- Inari Medical Acquires LimFlow For $250M In CashBenzinga Newsdesk - Nov 1, 2023, 4:06PM
- Earnings Scheduled For November 1, 2023Benzinga Insights - Nov 1, 2023, 7:19AM
Friday, September 29, 2023
Thursday, August 03, 2023
- Inari Medical Stock Gained 21% on Thursday - Here's Why It SoaredVandana Singh - Aug 3, 2023, 4:09PM
- Inari Medical shares are trading higher after the company reported better-than-expected Q2 results.Benzinga Newsdesk - Aug 3, 2023, 2:15PM
- Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On ThursdayLisa Levin - Aug 3, 2023, 10:57AM
- Morgan Stanley Reiterates Overweight on Inari Medical, Maintains $83 Price TargetBenzinga Newsdesk - Aug 3, 2023, 10:54AM
Wednesday, August 02, 2023
Wednesday, July 26, 2023
Wednesday, July 19, 2023
- Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $65Benzinga Newsdesk - Jul 19, 2023, 11:55AM
- Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023Benzinga Insights - Jul 19, 2023, 11:00AM
- Baird Initiates Coverage On Inari Medical with Outperform Rating, Announces Price Target of $79Benzinga Newsdesk - Jul 19, 2023, 4:50AM